Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis

Journal of Neuroimmunology

Volumn 87, Issue 1-2, 1998, Pages 73-81

  Schratzberger, P ^a   Geiseler, A ^a   Dunzendorfer, S ^a   Reinisch, N ^a   Kahler C M ^a   Wiedermann, C J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

B lymphocytes; Chemotaxis; Inflammatory mediators; Neuroimmunology; T lymphocytes

Indexed keywords

RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; B LYMPHOCYTE; CHEMOTAXIS; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; NEUROIMMUNOLOGY; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; CHOLERA TOXIN; ENZYME INHIBITORS; HUMANS; LYMPHOCYTES; PEPTIDES; PHOSPHOTRANSFERASES; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; SECRETIN; VASOACTIVE INTESTINAL PEPTIDE; VIRULENCE FACTORS, BORDETELLA;

EID: 0032126159     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00043-5     Document Type: Article

References (34)

1. Bacon, K.B., Camp, R.D.R., 1990. Interleukin-8-induced in vitro human lymphocyte migration is inhibited by cholera and pertussis toxins and inhibitors of protein kinase C. Biochem. Biophys. Res. Commun. 169, 1099-1104.
2. Cheng, P.P.-J., Sreedharan, S.P., Kishiyama, J.L., Goetzl, E.J., 1993. The SKW 6.4 line of human B lymphocytes specifically binds and responds to vasoactive intestinal peptide. Immunology 79, 64-68.
3. Goetzl, E.J., Sreedharan, S.P., 1992. Mediators of communication and adaptation in the neuroendocrine and immune systems. FASEB J. 6, 2646-2652.
4. Hassner, A., Lau, M.S., Goetzl, E.J., Adelman, D.C., 1993. Isotypespecific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide. J. Allergy Clin. Immunol. 92, 891-901.
5. Huang, M., Itoh, H., Lederis, K., Rorstad, O., 1989. Evidence that vascular actions of PHI are mediated by a VIP-preferring receptor. Peptides 10, 993-1001.
6. Ishihara, T., Shigemoto, R., Mori, K., Takahashi, K., Nagata, S., 1992. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8, 811-819.
7. Jinquan, T., Møller, B., Storgaard, M., Mukaida, N., Bonde, J., Gruunet, N., Black, F.T., Larsen, C.G., Matsushima, K., Thestrup-Pedersen, K., 1997. Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects. J. Immunol. 158, 475-484.
8. Johnston, J.A., Taub, D.D., Lloyd, A.R., Conlon, K., Oppenheim, J.J., Kelvin, D.J., 1994. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J. Immunol. 153, 1762-1768.
9. Koh, S.W.M., 1991. Signal transduction through the vasoactive intestinal peptide receptor stimulates phosphorylation of the tyrosine kinase PP60c-src. Biochem. Biophys. Res. Commun. 174, 452-458.
10. Lutz, E.M., Sheward, W.J., West, K.M., Morrow, J.A., Fink, G., Harmar, A.J., 1993. The VIP2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334, 3-8.
11. Mathew, R.C., Cook, G.A., Blum, A.M., Metwali, A., Felman, R., Weinstock, J.V., 1992. VIP stimulates T lymphocytes to release IL-5 in murine Schistosomiasis Mansoni infection. J. Immunol. 148, 3572-3577.
12. 2+ influx activates a constitutive NOS in dispersed gastric muscle cells. Am. J. Physiol. 265, G660-671.
13. Ottaway, C.A., 1987. Selective effects of vasoactive intesinal peptide on the mitogenic response of murine T cells. Immunology 62, 291-297.
14. Ottaway, C.A., 1991. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol. Clin. North Am. 20, 511-529.
15. Ottaway, C.A., 1992a. Role of sulfhydryl groups in the binding of vasoactive intestinal peptide to its receptor on murine lymphocytes. J. Neuroimmunol. 39, 49-56.
16. Ottaway, C.A., 1992b. Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly. J. Neuroimmunol. 38, 241-253.
17. Ottaway, C.A., Lay, T.E., Greenberg, G.R., 1990. High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes. J. Neuroimmunol. 29, 149-155.
18. Robberecht, P., Gourlet, P., Vertongen, P., Svoboda, M., 1996. Characterization of the VIP receptor from SUP T1 lymphoblasts. Adv. Neuroimmunol. 6, 49-57.
19. Rola-Pleszczynski, M., Bolduc, D., Pierre, S., 1985. The effects of vasoactive intestinal peptide on human natural killer cell function. J. Immunol. 135, 2569-2573.
20. Sacerdote, P., Ruff, M.R., Pert, C.P., 1987. Vasoactive intestinal peptide 1-12: a ligand for the CD4 (T4)/human immunodeficiency virus receptor. J. Neurosci. Res. 18, 102-107.
21. Said, S.I., 1986. Vasoactive intestinal peptide. J. Endocrinol. Invest. 9, 191-200.
22. Said, S.I., 1994. Vasoactive intestinal polypeptide in the respiratory tract. In: Kaliner, M.A., Barnes, P.J., Kunkel, G.H.H., Baraniuk, J.N. (Eds.), Neuropeptides in Respiratory Medicine. Marcel Dekker, New York, pp. 143-156.
23. Schratzberger, P., Reinisch, N., Prodinger, W.M., Kähler, C.M., Sitte, B.A., Bellmann, R., Fischer-Colbrie, R., Winkler, H., Wiedermann, C.J., 1997a. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J. Immunol. 158, 3895-3901.
24. Schratzberger, P., Dunzendorfer, S., Reinisch, N., Kähler, C.M., Wiedermann, C.J., 1997b. Interleukin-8-induced human peripheral blood B lymphocyte chemotaxis in vitro. Immunol. Lett. 58, 167-170.
25. 2+ transients. Endocrinology 134, 596-602.
26. Sreedharan, S.P., Patel, D.R., Huang, J.-X., Goetzl, E.J., 1993. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem. Biophys. Res. Commun. 193, 546-553.
27. Svoboda, M., Tastenoy, M., Van Rampelbergh, J., Goossens, J.-F., De Neef, P., Waelbroeck, M., Robberecht, P., 1994. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 205, 1617-1624.
28. Tomhave, E.D., Richardson, R.M., Didsbury, J.R., Menard, L., Snyderman, R., Ali, H., 1994. Cross-desensitization of receptors for peptide chemoattractants: characterization of a new form of leukocyte regulation. J. Immunol. 153, 3267-3275.
29. Usdin, T.B., Bonner, T.I., Mezey, E., 1994. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135, 2662-2680.
30. Wang, H.-Y., Xin, Z., Tang, H., Ganea, D., 1996. VIP inhibits IL-4 production in murine T cells by a post-transcriptional mechanism. J. Immunol. 156, 3243-3253.
31. Wiedermann, C.J., Sertl, K., Zipser, B., Hill, J.M., Pert, C.B., 1988. Vasoactive intestinal peptide receptors in rat spleen and brain: a shared communication network. Peptides 9 (suppl.), 21-28.
32. Wiedermann, C.J., Wiedermann, F.J., Apperl, A., Kieselbach, G., Konwalinka, G., Braunsteiner, H., 1989. In vitro human polymorphonuclear chemokinesis and human monocyte chemotaxis are different activities of amino-terminal and carboxy-terminal substance P. Naunyn-Schmiedeberg's Arch. Pharmacol. 340, 185-190.
33. Wilkinson, P.C., 1988. Micropore filter methods for leukocyte chemotaxis. Methods Enzymol. 162, 38-50.
34. Xia, M., Gaufo, G.O., Wang, Q., Sreedharan, S.P., Goetzl, E.J., 1996. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors. J. Immunol. 157, 1132-1138.